Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

J Hosp Infect. 2021 Mar:109:29-31. doi: 10.1016/j.jhin.2020.11.030. Epub 2020 Dec 15.

IPC Program Working Group:
C Cosentino⁷, L Alibardi⁸, L De Marchis⁷, M Aiuti⁹, A Carraturo⁸, S Parrocchia⁸, A Mecozzi¹⁰, A De Meo¹¹

¹ Infectious Diseases Unit, S.M. Goretti Hospital, Latina, Italy. Electronic address: [email protected].
² Infectious Diseases Unit, S.M. Goretti Hospital, Latina, Italy.
³ Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy; National Institute for Infectious Diseases, IRCCS Lazzaro Spallanzani, Rome, Italy.
⁴ Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
⁵ Department of Public Health, University of Naples Federico II, Naples, Italy.
⁶ Infectious Diseases Unit, S.M. Goretti Hospital, Latina, Italy; Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
⁷ Intensive Care Unit, S.M. Goretti Hospital, Latina, Italy.
⁸ Health Management P.O. Nord ASL Latina, S.M. Goretti Hospital, Latina, Italy.
⁹ Emergency Medicine Unit, S.M. Goretti Hospital, Latina, Italy.
¹⁰ Drug Policy Area, General Directorate for Health, The Lazio Region, Rome, Italy; Hospital Pharmacy, S.M. Goretti Hospital, Latina, Italy.
¹¹ Hospital Pharmacy, S.M. Goretti Hospital, Latina, Italy.

No abstract available

MeSH terms